Higher patient perceived side effects related to higher daily doses of inhaled corticosteroids in the community: A cross-sectional analysis

Juliet M. Foster*, Lorna Aucott, Rik H. W. van der Werf, Mariken J. van der Meijden, Gysbert Schraa, Dirkje S. Postma, Thys van der Molen

*Bijbehorende auteur voor dit werk

OnderzoeksoutputAcademicpeer review

34 Citaten (Scopus)


The range and extent of inhaled corticosteroid (ICS) side effects experienced by patients in the general community are likely to be underestimated. Aims: To identify the side effects of ICS perceived by patients in the community and, through the use of a self-report questionnaire, measure their intensity, prevalence and relationship with daily medication dose. Methods: Focus groups and in-depth interviews were conducted to identify side effects that patients associated with their use of ICS. In an international multicentre cross-sectional survey, 395 inhaler users from community pharmacy (mean age 50, 53% female), divided into 4 daily dosage groups (beta(2)-agonist without ICS n = 66, beclometasone dipropionate (BDP) equivalent ICS low dose 800 mu g, n = 69) reported how much they were affected by these side effects on a 7-point Likert scale.

Originele taal-2English
Pagina's (van-tot)1318-1336
Aantal pagina's19
TijdschriftRespiratory Medicine
Nummer van het tijdschrift8
StatusPublished - aug.-2006

Citeer dit